Hydrogen oxygen inhalation is mainly used as an adjunctive therapy for the treatment of chronic obstructive pulmonary disease, which still needs to be combined with comprehensive treatment means such as sputumization and bronchodilatation.
Relevant studies have proved that hydrogen molecules are characterized by anti-inflammatory, antioxidant and rapid diffusion. For patients with acute exacerbation of chronic obstructive pulmonary disease, hydrogen oxygen therapy is superior to simple oxygen therapy, and is safe and well tolerated. COPD itself is a disease of restricted and completely irreversible airflow, so inhalation of hydroxide can only relieve symptoms of shortness of breath and other respiratory distress to a certain extent.
Patients with acute exacerbations are often co-infected and may require anti-infective treatment, while bronchodilators and phlegmolytic drugs are also important adjunctive therapies.